lithospermate b has been researched along with Injury, Myocardial Reperfusion in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duan, J; Guan, Y; Guo, C; Quan, W; Wang, Y; Wen, A; Xi, M; Yin, Y; Zhou, D; Zhu, Y | 1 |
Guo, C; Quan, W; Wang, Y; Wei, G; Wen, A; Weng, Y; Xi, M; Zhou, D; Zhu, Y | 1 |
Ou-Yang, JH; Xiao, YL; Yang, LM | 1 |
3 other study(ies) available for lithospermate b and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Antioxidant properties of magnesium lithospermate B contribute to the cardioprotection against myocardial ischemia/reperfusion injury in vivo and in vitro.
Topics: Animals; Antioxidants; Drugs, Chinese Herbal; Humans; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardial Reperfusion Injury; Protective Agents; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Superoxide Dismutase | 2013 |
Magnesium lithospermate B reduces myocardial ischemia/reperfusion injury in rats via regulating the inflammation response.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Creatine Kinase, MB Form; Cytokines; Disease Models, Animal; Drugs, Chinese Herbal; Electrocardiography; I-kappa B Proteins; Inflammation; Inflammation Mediators; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NF-kappa B; NF-KappaB Inhibitor alpha; Peroxidase; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Troponin I | 2013 |
[Inhibition of magnesium lithospermate B on the c-Jun N-terminal kinase 3 mRNA expression in cardiomyocytes encountered ischemia/reperfusion injury].
Topics: Animals; Cardiotonic Agents; Drugs, Chinese Herbal; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2003 |